Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma.
about
Assessment of baicalin in mouse blood by monoclonal antibody-based icELISA.Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice.Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.Monoclonal antibody therapy in multiple myeloma.Automated DBS microsampling, microscale automation and microflow LC-MS for therapeutic protein PK.
P2860
Preclinical pharmacokinetics of MFGR1877A, a human monoclonal antibody to FGFR3, and prediction of its efficacious clinical dose for the treatment of t(4;14)-positive multiple myeloma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Preclinical pharmacokinetics o ...... 14)-positive multiple myeloma.
@en
Preclinical pharmacokinetics o ...... 14)-positive multiple myeloma.
@nl
type
label
Preclinical pharmacokinetics o ...... 14)-positive multiple myeloma.
@en
Preclinical pharmacokinetics o ...... 14)-positive multiple myeloma.
@nl
prefLabel
Preclinical pharmacokinetics o ...... 14)-positive multiple myeloma.
@en
Preclinical pharmacokinetics o ...... 14)-positive multiple myeloma.
@nl
P2093
P2860
P1476
Preclinical pharmacokinetics o ...... 14)-positive multiple myeloma.
@en
P2093
Amrita V Kamath
Denise Jin
Janet Tien
Jean-Philippe Stephan
Lisa A Damico-Beyer
Priyanka Gupta
P2860
P2888
P304
P356
10.1007/S00280-011-1807-5
P577
2011-12-28T00:00:00Z